Contract Research Organization (CRO) Services Market Forecasts to 2024

  • Product Code:
    RP-ID-10082698
  • Published Date:
    Apr 2019
  • Region:
    Global
  • Pages:
    116
  • Category:
    Healthcare & Pharmaceuticals
  • Publisher:
    Infoholic Research
Global Pharma Contract Research Organization Market – Drivers, Opportunities, Trends, and Forecast: 2018–2024
Overview: Contract Research Organization (CRO), also sometimes referred as also referred as clinical research organization are key constituent of the drug development process, offers range of services to pharmaceutical and biopharmaceutical companies. CRO’s can provide services such as early phase development services (includes discovery studies, chemistry, manufacturing & control), Pharmacokinetics/Pharmacodynamics (PK/PD), toxicology testing, clinic research services (Phase I, Phase II, Phase III, Phase IV), laboratory services, analytical and bioanalytical testing, physical characterization, and consulting services. CRO also extend their services to governmental institutes, Universities, in addition to research institutions. CRO’s help in the drug development various major diseases such as oncology, cardiovascular disease, diabetes, infectious diseases, CNS disorders, respiratory disorders and other disorders.
The market for pharma contract research organization is driven by increasing outsourcing of research and development by pharmaceutical companies, increasing clinical trials across the globe, increasing number of patent expiration and growth in biopharmaceuticals market are some of the factors driving the growth of CRO market, whereas, lack of skilled personnel and quality issues related to services offered by CROs are limiting the growth of CRO market to an extent.
Market Analysis: The “Global Pharma Contract Research Organization market” is estimated to witness a CAGR of 8.2% during the forecast period 2018–2024. The global market is analyzed based on three segments –Service type, therapeutic area and regions.
Regional Analysis: The regions covered in the report are the North America, Europe, Asia Pacific, and Rest of the World (ROW). North America is the major shareholder in the global pharma contract research organization market, followed by Europe. Increasing growth of biopharmaceutical market, high quality standards of pharma and biopharma industry and availability of advanced technologies makes North America major shareholder of pharma CRO market. Asia Pacific is expected to grow at high CAGR during forecasted period due to increasing research activities, growing patient pool, and flexible regulatory environment for clinical trials.
Service Type Analysis: The pharma contract research organization market by service type is segmented into discovery, preclinical studies, clinical studies and others. Among these, clinical study services accounted for the highest market share in 2017, due to increasing prevalence of lifestyle and metabolic diseases, growth in the elderly population and increasing clinical trials globally.
Therapeutic Area Analysis: The market by therapeutic area is segmented into oncology, infectious disease, cardiovascular disease, CNS disorders, immunological disorders, respiratory disease, diabetes and others. Oncology occupied a major market share in 2017 and is expected to remain same for next five years. This is due to increasing global prevalence of cancer across the globe and high number of ongoing clinical trials in this segment.
Key Players:
Laboratory Corporation of America Holdings (Covance), Charles River Laboratories, Inc., Pharmaceutical Product Development Inc., IQVIA Holdings Inc., PAREXEL International Corporation, ICON plc, Syneos Health, Inc., Medpace Holdings, Inc., Envigo, Evotec AG, Eurofins Scientific, PRA Health Sciences, Inc., WuXi AppTec, Inc., SGS SA, EPS International, Genscript Biotech Corporation and niche players.
Competitive Analysis: There is increase in acquisitions and mergers by the CRO’s in recent years to gain global foothold in the highly competitive CRO market. For instance, in August 2017, LabCorp acquired CRO Chiltern for $1.2 billion, which will become part of the company’s Covance Drug Development business. This will strengthen LabCorp’s Position as a Global Life Sciences Company with Leading Diagnostics and Drug Development Businesses. In August 2017, Avista Healthcare and CRO Envigo have entered into a definitive merger agreement under which Envigo will become a wholly owned subsidiary of Avista. In August 2017, Mercachem and Syncom, two of the leading European drug discovery Contract Research Organizations (CRO), announced the merger of two companies that will result in the formation of Mercachem-Syncom Group, with more than 300 employees and operations in Nijmegen and Groningen. In addition, the company has numerous partnership to enhance their service capabilities. For instance, In March 2018, PAREXEL announced a partnership with CHA Medical Group to increase its early phase clinical development capabilities in South Korea. WuXi AppTec entered into partnership with biopharmaceutical company Antengene Corporation to accelerate drug development for oncology.
Benefits: The report provides complete details about the services offered by pharma contract research organizations in various therapeutic verticals and regions. With that, key stakeholders can know about the major trends, drivers, investments, and vertical player’s initiatives. Moreover, the report provides details about the major challenges that are going to impact on the market growth. Additionally, the report gives the complete details about the key business opportunities to key stakeholders to expand their business and capture the revenue in the specific verticals to analyze before investing or expanding the business in this market.
Key Stakeholders:

Table of Contents
1 Industry Outlook 10
1.1 Industry Overview 10
1.1.1 Industry Trends 11
1.1.2 R&D pipeline in pharmaceutical industry 11
1.2 Total addressable market 12
2 Report Outline 14
2.1 Report Scope 14
2.2 Report Summary 14
2.3 Research Methodology 15
2.4 Report Assumptions 15
3 Market Snapshot 17
3.1 Market Definition – Infoholic Research 17
3.2 Need of CRO 17
3.3 History of CRO 17
3.4 Segmented Addressable Market (SAM) 18
3.5 Trends of the pharma contract research organization market 18
3.6 Related Markets 19
3.6.1 Pharmaceutical Contract manufacturing organization market 19
3.6.2 Drug discovery outsourcing 20
4 Market Outlook 21
4.1 Funding Scenario 24
4.2 Process of Drug Development 25
4.3 Market segmentation 25
4.4 PEST Analysis 26
4.5 Porter 5(Five) Forces 28
5 Market Characteristics 29
5.1 DRO – Global pharma contract research organization Market Dynamics 29
5.1.1 Drivers 29
5.1.1.1 Upsurge in outsourcing of R&D activities 29
5.1.1.2 Rising number of clinical trials across the globe 30
5.1.2 Opportunities 31
5.1.2.1 Growth in the biopharmaceutical market 31
5.1.2.2 Increasing number of deals to develop new compounds for rare disease 31
5.1.3 Restraints 31
5.1.3.1 Quality issues related to services offered by CRO 31
5.1.3.2 Lack of trained professionals 32
5.2 DRO – Impact Analysis 33
5.3 Key Stakeholders 33
6 Service type: Market Size & Analysis 35
6.1 Overview 35
6.2 Discovery services 36
6.3 Preclinical study services 38
6.3.1 Pharmacokinetics/Pharmacodynamics 40
6.3.2 Toxicology testing 40
6.3.3 Others 41
6.4 Clinical study services 41
6.4.1 Phase I 43
6.4.2 Phase II 43
6.4.3 Phase III 43
6.4.4 Phase IV 43
6.5 Others 44
7 Therapeutic indication: Market Size & Analysis 45
7.1 Overview 45
7.2 Oncology 46
7.3 Respiratory disease 46
7.4 CNS disorder 46
7.5 Infectious disease 47
7.6 Cardiovascular disease 47
7.7 Immunological disorder 47
7.8 Diabetes 47
7.9 Others 48
8 Regions: Market Size and Analysis 49
8.1 Overview 49
8.2 North America 50
8.3 Europe 52
8.4 Asia Pacific 53
8.5 Rest of the World 55
9 Competitive Landscape 56
9.1 Overview 56
10 Vendor Profiles 59
10.1 Charles River Laboratories, Inc. 59
10.1.1 Overview 59
10.1.2 Charles River Laboratories, Inc.: Recent Developments 60
10.1.3 Business Units 62
10.1.4 Geographic Revenue 63
10.1.5 Business Focus 64
10.1.6 SWOT Analysis 65
10.1.7 Business Strategies 65
10.2 Laboratory Corporation of America Holdings (LABCORP) 66
10.2.1 Overview 66
10.2.2 Laboratory Corporation of America Holdings: Recent Developments 68
10.2.3 Business Units 70
10.2.4 Geographic Revenue 71
10.2.5 Business Focus 71
10.2.6 SWOT Analysis 72
10.2.7 Business Strategies 72
10.3 IQVIA HOLDINGS INC. 73
10.3.1 Overview 73
10.3.2 Business Units 76
10.3.3 Geographic Revenue 76
10.3.4 Business Focus 77
10.3.5 SWOT Analysis 78
10.3.6 Business Strategies 78
10.4 Pharmaceutical Product Development Inc 79
10.4.1 Overview 79
10.4.2 Business Focus 81
10.4.3 SWOT Analysis 81
10.4.4 Business Strategy 81
10.5 ICON PLC 82
10.5.1 Overview 82
10.5.2 Geographic Revenue 85
10.5.3 Business Focus 86
10.5.4 SWOT Analysis 86
10.5.5 Business Strategies 87
10.6 PAREXEL International Corporation 88
10.6.1 Overview 88
10.6.2 Business Units 90
10.6.3 Geographic Revenue 91
10.6.4 Business Focus 92
10.6.5 SWOT Analysis 93
10.6.6 Business Strategies 93
11 Companies to Watch for 95
11.1 PRA HEALTH SCIENCES, INC. 95
11.1.1 Overview 95
11.2 Syneos Health Inc 96
11.2.1 Overview 96
11.3 WuXi AppTec 99
11.3.1 Overview 99
11.4 Medpace Holdings, Inc. 100
11.4.1 Overview 100
11.5 SGS SA 101
11.5.1 Overview 101
11.6 Envigo 103
11.6.1 Overview 103
11.7 EPS INTERNATIONAL 105
11.7.1 Overview 105
11.8 EVOTEC AG 106
11.8.1 Overview 106
11.9 GenScript Biotech Corporation 110
11.9.1 Overview 110
11.10 Eurofins Scientific 111
11.10.1 Overview 111
Annexure 115
 Acronyms 115


Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report
Laboratory Corporation of America Holdings (Covance), Charles River Laboratories, Inc., Pharmaceutical Product Development Inc., IQVIA Holdings Inc., PAREXEL International Corporation, ICON plc, Syneos Health, Inc., Medpace Holdings, Inc., Envigo, Evotec AG, Eurofins Scientific, PRA Health Sciences, Inc., WuXi AppTec, Inc., SGS SA, EPS International, Genscript Biotech Corporation and niche players
Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report

Related Reports